PCM
EVFM

Pentwater Capital Management’s Evofem Biosciences, Inc. Common Stock EVFM Stock Holding History

Pentwater Capital Management’s Portfolio EVFM Stock Details EVFM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-3,333
Closed -$118K – 279
2020
Q3 		$118K Sell
3,333
-3,334
-50% -$145K ﹤0.01% 217
2020
Q2 		$283K Buy
+6,667
New +$449K 0.01% 140

Other funds holding EVFM

Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
HA
Heartland Advisors Milwaukee, Wisconsin $1.96B AUM 28.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
TWMP
Taylor Wealth Management Partners Boston, Massachusetts $176M AUM 14.65% 1-Year Est. Return

Pentwater Capital Management's EVFM Position: Q4 2020 in Review

Pentwater Capital Management sold out of Evofem Biosciences, Inc. Common Stock (EVFM) in Q4 2020, closing a stake of 3,333 shares — an estimated $118K sold.

Pentwater Capital Management first reported a position in EVFM in Q2 2020 and held it in 2 quarters. The position peaked at $283K in Q2 2020. 93 funds tracked by Wall St. Rank hold EVFM as of Q4 2020.

  • Pentwater Capital Management reported no remaining Evofem Biosciences, Inc. Common Stock position as of Q4 2020 after selling out during the quarter.
  • Pentwater Capital Management sold 3,333 Evofem Biosciences, Inc. Common Stock shares in Q4 2020, an estimated $118K.
  • Pentwater Capital Management first reported a position in Evofem Biosciences, Inc. Common Stock in Q2 2020 and held it in 2 quarters.
  • Pentwater Capital Management's Evofem Biosciences, Inc. Common Stock position peaked at $283K in Q2 2020.
  • 93 funds tracked by Wall St. Rank held Evofem Biosciences, Inc. Common Stock as of Q4 2020.

Based on Pentwater Capital Management's 13F filing for Q4 2020, filed 16 Feb 2021.